Citryll Bv
Clinical trials sponsored by Citryll Bv, explained in plain language.
-
New hope for arthritis sufferers? CIT-013 drug trial begins
Disease control Recruiting nowThis study tests whether a new drug called CIT-013 can reduce disease activity in adults with moderately active rheumatoid arthritis. About 88 participants will receive either CIT-013 or a placebo every two weeks for six weeks. Researchers will check joint swelling, pain, and saf…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New drug CIT-013 aims to calm painful skin flares
Disease control Recruiting nowThis study tests a new drug called CIT-013 for people with hidradenitis suppurativa (HS), a painful skin condition. About 96 adults with moderate to severe HS will receive either a low or high dose of CIT-013 or a placebo every two weeks for 12 weeks. The main goal is to see if C…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Scientists use PET scans to track new arthritis drug in the body
Knowledge-focused Recruiting nowThis study uses special PET scans to track where a new drug, CIT-013, goes in the body of 12 people with rheumatoid arthritis. The drug aims to calm inflammation caused by immune cells. The main goal is to see how the drug spreads through the body, not to test if it works as a tr…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated May 26, 2026 04:58 UTC